STAGE IIB PANCREATIC CANCER AJCC V8
Clinical trials for STAGE IIB PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIB PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stall pancreatic cancer growth
Disease control OngoingThis study tests whether a combination of lenvatinib and pembrolizumab can help control advanced pancreatic cancer that cannot be removed by surgery. About 28 adults whose cancer has not worsened after initial treatment will receive these drugs as maintenance therapy. The goal is…
Matched conditions: STAGE IIB PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New drug cocktail aims to starve pancreatic tumors
Disease control OngoingThis early-stage trial tests a combination of two drugs—calaspargase and cobimetinib—in about 15 people with advanced pancreatic cancer that has spread. Calaspargase works by cutting off a key nutrient that cancer cells need to grow, while cobimetinib blocks a protein that helps …
Matched conditions: STAGE IIB PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC